| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.18 | 6e-05 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.17 | 0.0003 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.0003 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.16 | 0.002 |